TACSTD2 and neoplasm: Functionally, TROP-2 promotes oncogenesis through activation of several signaling cascades, including PTEN/PI3K/Akt, MAPK/ERK, JAK/STAT, ErbB, TGF-β, and WNT/β-catenin pathways, thereby enhancing tumor cell survival and proliferation [242].